All the top Biotech & Pharma news in one daily newsletter.

Want to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

Looking to reach an audience of 1500+ biotech and pharma professionals? Let’s chat. 👍

THE GOOD
Business Development

GSK continues Shingrix supply deal to China with Chongqing Zhifei Biological Products, but agreed upon volume lower than anticipated
Vaccine, shingles - Read more

THE GOOD
Clinical Trials

Protara Therapeutics showcases positive results from ongoing TARA-002 (targeting Toll Like Receptor 4) Ph2 trial in bladder cancer
Cell therapy, bladder cancer - Read more

CG Oncology touts durability data from Ph3 of cretostimogene grenadenorepvec in bladder cancer
Oncolytic immunotherapy, bladder cancer - Read more

NeuroSense Therapeutics touts “statistically significant” Ph2 results from 18-month data analysis of PrimeC (ciprofloxacin and celecoxib combo) in ALS
Small molecule, amyotrophic lateral sclerosis - Read more

THE GOOD
Fundraises

Atlas Venture closes biotech-focused Fund XIV at $450M
Biotech investing, venture capital, early-stage investing - Read more

Nuvig Therapeutics $161M Series B, aiming for next-gen, non-immune suppressing autoimmune disorder therapies
Fc fragment, autoimmune disorders, chronic inflammatory demyelinating polyneuropathy, bullous pemphigoid - Read more

NTx $15M in venture debt, sustainable biologics manufacturing
mRNA vaccines, protein therapeutics, manufacturing, sustainability - Read more

Newcells £1.2M ($1.5M) raise, non-animal models for drug development
Non-animal models, drug development, tissue mimic - Read more

Cleery $106M Series C extension, AI-powered cardiovascular imaging technology
Software, heart disease, medtech, AI, imaging - Read more

PRESENTED BY YOU?
Get the attention of 1500+ Biotech & Pharma Professionals 🤩

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

⬇️ More Good News ⬇️

THE GOOD
Investments

Eli Lilly to invest a “Pleasant” $3B into Wisconsin, USA-based injectables manufacturing, fill-finish site
Site expansion, injectables, fill-finish - Read more 

Amgen commits $1B for second drug substance site in North Carolina, USA
New facility, drug substance manufacturing - Read more

myTomorrows health tech, CRO opens new operations hub in Delhi, India
Clinical research organization, clinical trial recruiting, health tech - Read more 

THE GOOD
Lawsuits

Insulet emerges victorious in patent spat with EOFlow, $452M in damages awarded
Medical device, insulin pump, diabetes - Read more

THE GOOD
Partnerships

GSK, Muna Therapeutics sign drug discovery and development pact focused on novel neurodegenerative disease small molecules
Small molecule, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis - Read more

Matica Bio, Treovir manufacturing partnership focused on G207 HSV-based oncolytic therapy
Oncolytic immunotherapy, glioblastoma, brain tumor, cancer, CDMO - Read more

Eckert & Ziegler signs radionuclide supply agreement to Ariceum Therapeutics
Radiopharm, radionuclide, isotope manufacturing - Read more

THE GOOD
Patient Access

UK’s NICE goes slow-and-steady with Eli Lilly’s tirzepatide roll-out so as to not overwhelm NHS
GLP-1, obesity - Read more

THE GOOD
Regulatory

FDA posts updated guidance on expediting accelerated approval withdrawals
Accelerated approval, regulatory guidance - Read more [PDF Page 18]

THE GOOD
Strategic Plans

United States Patent and Trademark Office withdraws controversial proposed patent group challenge rule
Pharma patent - Read more [Paywall]

ENJOYING THESE NEWSLETTERS?
Support TLDR Biotech🧬🦠🔬 

I’m offering this newsletter for free so it can get out to as many people as possible.

If you’re getting value out of these daily compilations, please consider a paid subscription (only $5/month) to support my continued work on this project.*

*Best of all, it’s a work-related news source that you can likely expense. 😉 

THE BAD
Layoffs

Agenus plots staff layoffs after last week’s CDMO business announcement
Monoclonal antibody, cancer, CDMO - Read more

THE UGLY
Marketing

AstraZeneca scolded by UK’s PCMPA after an “an anonymous, contactable complainant who described themselves as an AstraZeneca employee” complained about LinkedIn promotional behavior of several “senior, care free colleagues”
Pharma marketing, LinkedIn - Read more 

THE UGLY
Public Health

Deadly, unknown disease outbreak in the DRC - 382 cases (over half in children under 5), 79 deaths
Infectious disease, disease outbreak - Read more [Paywall]

THE UGLY
Research

H5N1 bird flu virus just needs a single mutation to become more efficiently infectious among humans
Infectious disease, bird flue (H5N1) - Read more [Paywall]

You’re all caught up on the latest Pharma & Biotech News!

TLDR Biotech wants to hear from you! 📣

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

Last thing - if you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here